Global Respiratory Inhaler Devices Market Analysis 2024: Size Forecast and Growth Prospects
Respiratory Inhaler Devices Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $38.54 billion in 2023 to $41.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.
The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $54.72 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Scope Of Respiratory Inhaler Devices Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Respiratory Inhaler Devices Market Overview
Market Drivers -
The growing prevalence of respiratory diseases is expected to propel the growth of the respiratory inhaler devices market going forward. Respiratory diseases are disorders that affect the lungs and the respiratory system, leading to breathing difficulties and impaired lung function. Respiratory inhaler devices are used to deliver medications directly to the lungs, providing fast and targeted relief for respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection and other respiratory conditions. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 tuberculosis (TB) cases were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the growing prevalence of respiratory diseases propels the growth of the respiratory inhaler devices market.
Market Trends -
Major companies operating in the respiratory inhaler devices market are adopting new technologies, such as metered dosage inhalers, to sustain their position in the market. A metered dosage inhaler (MDI) is a portable aerosol device that delivers a precise dose of medication to the lungs in the form of a mist or inhaled spray. For instance, in February 2022, AptarGroup Inc., a US-based consumer dispensing packaging and drug delivery device manufacturer, launched HeroTracker Sense. This advanced digital respiratory health solution converts a conventional metered dosage inhaler (pMDI) into a smart, connected medical apparatus. HeroTracker Sense is made to track patients' use of MDIs and facilitate better adherence to their recommended therapy to improve the lives of patients worldwide who suffer from chronic respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and other respiratory conditions brought on by COVID-19. HeroTracker Sense provides valuable analytics and insights into patient training, onboarding and performance to healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.
The respiratory inhaler devices market covered in this report is segmented –
1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
Get an inside scoop of the respiratory inhaler devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13014&type=smp
Regional Insights -
North America was the largest region in the respiratory inhaler devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies -
Major players in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.
Table of Contents
1. Executive Summary
2. Respiratory Inhaler Devices Market Report Structure
3. Respiratory Inhaler Devices Market Trends And Strategies
4. Respiratory Inhaler Devices Market – Macro Economic Scenario
5. Respiratory Inhaler Devices Market Size And Growth
…..
27. Respiratory Inhaler Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment